JPWO2020240472A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020240472A5
JPWO2020240472A5 JP2021571513A JP2021571513A JPWO2020240472A5 JP WO2020240472 A5 JPWO2020240472 A5 JP WO2020240472A5 JP 2021571513 A JP2021571513 A JP 2021571513A JP 2021571513 A JP2021571513 A JP 2021571513A JP WO2020240472 A5 JPWO2020240472 A5 JP WO2020240472A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
weight
formulation
pharmaceutically acceptable
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021571513A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022534776A (ja
JP7768769B2 (ja
JP2022534776A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/055083 external-priority patent/WO2020240472A1/en
Publication of JP2022534776A publication Critical patent/JP2022534776A/ja
Publication of JPWO2020240472A5 publication Critical patent/JPWO2020240472A5/ja
Publication of JP2022534776A5 publication Critical patent/JP2022534776A5/ja
Priority to JP2024215483A priority Critical patent/JP2025038034A/ja
Priority to JP2025183379A priority patent/JP2026021451A/ja
Application granted granted Critical
Publication of JP7768769B2 publication Critical patent/JP7768769B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021571513A 2019-05-28 2020-05-28 リゾチームを含む広域スペクトル抗菌製剤およびその使用方法 Active JP7768769B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024215483A JP2025038034A (ja) 2019-05-28 2024-12-10 リゾチームを含む広域スペクトル抗菌製剤およびその使用方法
JP2025183379A JP2026021451A (ja) 2019-05-28 2025-10-30 リゾチームを含む広域スペクトル抗菌製剤およびその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962853215P 2019-05-28 2019-05-28
US62/853,215 2019-05-28
PCT/IB2020/055083 WO2020240472A1 (en) 2019-05-28 2020-05-28 Wide-spectrum antibacterial pharmaceutical formulations comprising lysozyme and methods of using the same

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2024215483A Division JP2025038034A (ja) 2019-05-28 2024-12-10 リゾチームを含む広域スペクトル抗菌製剤およびその使用方法
JP2025183379A Division JP2026021451A (ja) 2019-05-28 2025-10-30 リゾチームを含む広域スペクトル抗菌製剤およびその使用方法

Publications (4)

Publication Number Publication Date
JP2022534776A JP2022534776A (ja) 2022-08-03
JPWO2020240472A5 true JPWO2020240472A5 (https=) 2023-06-14
JP2022534776A5 JP2022534776A5 (https=) 2023-06-14
JP7768769B2 JP7768769B2 (ja) 2025-11-12

Family

ID=73551002

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021571513A Active JP7768769B2 (ja) 2019-05-28 2020-05-28 リゾチームを含む広域スペクトル抗菌製剤およびその使用方法
JP2024215483A Pending JP2025038034A (ja) 2019-05-28 2024-12-10 リゾチームを含む広域スペクトル抗菌製剤およびその使用方法
JP2025183379A Pending JP2026021451A (ja) 2019-05-28 2025-10-30 リゾチームを含む広域スペクトル抗菌製剤およびその使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024215483A Pending JP2025038034A (ja) 2019-05-28 2024-12-10 リゾチームを含む広域スペクトル抗菌製剤およびその使用方法
JP2025183379A Pending JP2026021451A (ja) 2019-05-28 2025-10-30 リゾチームを含む広域スペクトル抗菌製剤およびその使用方法

Country Status (12)

Country Link
US (3) US20200376094A1 (https=)
EP (1) EP3976093A4 (https=)
JP (3) JP7768769B2 (https=)
CN (1) CN114126643A (https=)
AR (1) AR119031A1 (https=)
BR (1) BR112021024001A2 (https=)
CA (1) CA3145530A1 (https=)
CO (1) CO2021017958A2 (https=)
IL (1) IL288531A (https=)
MX (1) MX2021014634A (https=)
TW (1) TW202110474A (https=)
WO (1) WO2020240472A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3928785B1 (en) * 2020-04-27 2024-07-31 Guangzhou Century Clinical Research Co., Ltd Medicament and food for use in preventing or treating novel coronavirus pneumonia covid-19
EP4144363A4 (en) * 2020-04-27 2024-05-29 Guangzhou Century Clinical Research Co., Ltd Drug, food and application of anti-coronavirus infection
WO2023133412A2 (en) * 2022-01-05 2023-07-13 Prophase Labs, Inc. Compositions having synergistic anti-viral action and methods for treating coronavirus
CN114503981A (zh) * 2022-01-07 2022-05-17 上海膜益信息科技有限公司 一种不分层防霉液及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK501686A (da) * 1986-10-20 1988-04-21 Otto Melchior Poulsen Enzymholdigt, baktericidt middel samt tandplejemidler og saarbehandlingsmidler, som indeholder det
CN1557485A (zh) * 2004-01-30 2004-12-29 大连帝恩生物工程有限公司 基因重组人溶菌酶在消除病原微生物感染炎症上的应用
CA2561876C (en) * 2004-04-08 2013-01-08 Kenneth Vincent Mason Antimicrobial compositions and methods for their use
CN1583170A (zh) * 2004-06-10 2005-02-23 安米 用于抗病毒抗耐药菌的人溶菌酶药物及其制法
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
WO2009051838A1 (en) * 2007-10-19 2009-04-23 Becton Dickinson And Company Methods and compositions for the detection of beta-lactamases
EP2349209A2 (en) * 2008-09-26 2011-08-03 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
UA48016U (ru) * 2010-01-25 2010-02-25 Илона Васильевна Ковач Способ профилактики кариеса зубов у детей 3-6 лет
UA68612U (ru) * 2012-02-07 2012-03-26 Дмитрий Викторович Дудар Способ лечения хронического рецидивирующего афтозного стоматита у больных целиакией
CA2905788C (en) * 2013-03-12 2022-08-16 Emily A. Stein Dental composition comprising chelator and base
CN110352237B (zh) * 2017-02-28 2023-01-10 精密生物集团有限公司 可以有益地调节针对呼吸道病毒感染的免疫应答的长双歧杆菌
EP3655020A4 (en) * 2017-07-17 2021-04-07 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Antibacterial methods and related kits
CN107899006A (zh) * 2017-11-28 2018-04-13 四川清舒乐科技有限公司 冲洗鼻腔的药物组合物及其制备方法

Similar Documents

Publication Publication Date Title
JP5869469B2 (ja) 鉄が病因に関与する肝臓疾患の処置
CN114786659A (zh) 用于治疗汉坦病毒感染的mek抑制剂
JP2024170583A5 (https=)
JP7464737B2 (ja) 肺上皮細胞の損傷及び／又は血管内皮細胞の損傷によって媒介される疾患の治療における低分子化合物の用途
JP2023076632A5 (https=)
JP2023540149A (ja) 抗ウイルス化合物の製剤
WO2025218456A1 (zh) 巴洛沙韦钠在治疗克里米亚-刚果出血热病毒感染方面的应用
JP2024129029A (ja) 呼吸器状態を処置するためのｔｒｐｃ６阻害剤
CN113633649A (zh) 瑞德西韦及其核苷的组合制剂在抗猪流行性腹泻病毒中的应用
TW200911303A (en) Powders for reconstitution
CN115813920B (zh) 1,2,4三唑并4,3-b哒嗪衍生物在制备治疗慢性肾病的药物中的应用
JP7399976B2 (ja) Ｃｏｖｉｄ－１９新型コロナ肺炎を予防又は治療する医薬品、食品及びその使用
JPWO2020240472A5 (https=)
TW202203946A (zh) 用於人或動物之慢性或急性之病毒感染症及/或敗血症之預防或治療的組成物
WO2005113492A1 (fr) Sels d'ambroxol analogues de cysteine, procedes d'elaboration et utilisations
JP2023524064A (ja) ウイルス感染を治療又は予防するためのクロファジミン組成物及び方法
RU2021139087A (ru) Антибактериальные фармацевтические препараты широкого спектра действия, содержащие лизоцим, и способы их применения
US20170128482A1 (en) Modified release pharmaceutical compositions of sofosbuvir and ribavirin
CN115666550A (zh) 用于预防和/或治疗冠状病毒的半胱氨酸蛋白酶抑制剂
AU2022410715B2 (en) Pharmaceutical combination for the treatment of the respiratory infection caused by sars-cov-2
US20230181498A1 (en) New use of n,n-bis-2-mercaptoethyl isophthalamide
CN104771384A (zh) 紫草素的医药用途
JP7854206B2 (ja) 肺線維症の予防または治療用の薬学製剤
CN118490680B (zh) 瑞香素在制备治疗病毒性肺炎的药物中的应用
US20230310467A1 (en) PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + REMDESIVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19